Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Revenue

v3.24.3
Note 6 - Revenue
 9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

Note 6. Revenue

 

The following table disaggregates net revenues by categories (in thousands):

 

   

Three Months Ended September 30,

  
   

2024

    

2023

  

Sales of products, net:

                

e-Commerce revenue

   $ 3,834     $ 2,931  

Pharmacy prescription and other revenue, net of PBM fees

     9,076       9,888  

Sub total

     12,910       12,819  

Revenues from services:

                

Pharmacy 340B contract revenue

     2,457       2,471  
                 

Revenues, net

   $ 15,367     $ 15,290  

  

   

Nine Months Ended September 30,

  
   

2024

    

2023

  

Sales of products, net:

                

e-Commerce revenue

   $ 10,210     $ 8,764  

Pharmacy prescription and other revenue, net of PBM fees

     30,922       9,888  

Sub total

     41,132       18,652  

Revenues from services:

                

Pharmacy 340B contract revenue

     8,717       2,471  
                 

Revenues, net

   $ 49,849     $ 21,123